Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chemotherapy-induced Peripheral Neuropathy × ART123 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Postoperative Stage II/III Colon Cancer 1 Chemotherapy-induced Peripheral Neuropathy 1

Interventions

poly(methyl methacrylate)-b-polycaprolactone-N-acetylcysteine 1 Paclitaxel 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 ART123 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05251727 2024-08-19

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

Veloxis Pharmaceuticals

Phase 1 Terminated

Chemotherapy-induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡